144/109 - Integration to Implementation (I to I) on Vitamin A interventions
| Organized by: Microutrient Forum Canada (Canada) | ||
|---|---|---|
| Track 3: Public Health Nutrition and Environment | ||
| Monday 16 October | 11.30 - 13.30 h. | Room 3 - Libertador B |
Introduction
Chairperson
Dr. Ian Darnton-Hill
Adjunct Professor. University of Sydney. Australia. Tufts University. USA.
Assigned Co-Chair
Dr. Irina Kovalskys
MD, Committee of Nutrition and Wellbeing. International Life Science Institute (ILSI). Buenos Aires. Argentina.
See biography
Scope of the problem and overview of the controversy; how the I to I approach will be applied
Speaker
Dr. Homero Martinez
Hospital Infantil de Mexico Federico Gomez. Mexico City, Mexico. Micronutrient Forum Secretariat. Ottawa, Canada.
Biological evidence for or against high dose supplementation
Speaker
Dr. Sherry Tanumihardjo
University of Wisconsin. USA.
Relative strengths and weaknesses of available interventions/program strategies to prevent or improve vitamin A status in individuals or populations
Speaker
Dr. Emorn Udomkesmalee
Senior Advisor, Institute of Nutrition. Mahidol University. Thailand. Adjunct Associate Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health. USA.
See biography
Country perspective. What are the implications of the current concern/debate on national efforts to prevent vitamin A deficiency in Guatemala
Speaker
MSc. Dora Inés Mazariegos Cordero
Nutritional Biochemistry Lab. Institute of Nutrition of Central America and Panama (INCAP). Guatemala.
Country perspective. What are the implications of the current concern/debate on national efforts to prevent vitamin A deficiency in Zambia
Speaker
Mr. Musonda Jonathan Mofu
Deputy Executive Director. National Food and Nutrition Commission of Zambia. Zambia.
What does it all mean and how might we move an agenda forward to address these challenges? A. Technical agencies
Speaker
Dr. Roland Kupka
Senior Advisor for Micronutrients. UNICEF. USA.
What does it all mean and how might we move an agenda forward to address these challenges? B. Clinical perspective
Speaker
Dr. Parminder S. Suchdev
Associate Professor of Pediatrics & Global Health. Emory University. Medical Epidemiologist. Nutrition Branch. Centers for Disease Control & Prevention. USA.
What does it all mean and how might we move an agenda forward to address these challenges? C. Enabling agencies
Speaker
